GSDMD and Alzheimer disease: Aβ1-42 could induce pyroptosis in MCNs via GSDMD cleavage to increase membrane permeability and LDH release. The inhibitors targeting on GSDMD can lessen the Aβ1-42–induced pyroptosis and the behavioral ability in AD.